Dr. Reddy’s Laboratories (NYSE:RDY) announces the launch of Amphetamine Sulfate Tablets USP, a therapeutic generic version of Arbor Pharmaceuticals’ Evekeo (amphetamine sulfate) Tablets.
The company also launched authorized generic version of USpharma’s NitroDur (nitroglycerin) Transdermal Infusion System.
According to IQVIA Health, U.S. brand and generic
sales for Evekeo and Nitrogylcerin Transdermal Patch products were ~$38M
and ~$14.7M, respectively for the year ended January 2020.
https://seekingalpha.com/news/3560406-dr-reddys-launches-two-products-in-u-s
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.